![Sudha Parasuraman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sudha Parasuraman
Technik-/Wissenschafts-/F&E-Leiter bei Ribon Therapeutics, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Eli Berlin | M | - |
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | - |
Bassil Dahiyat | M | 53 |
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | 2 Jahre |
Larry Lasky | M | 73 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | - |
Marian Nakada | M | - |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 5 Jahre |
Gregory Copeland | M | - |
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | - |
Jon Root | M | 64 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | - |
Peter Svennilson | M | 62 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 7 Jahre |
Emma Reeve | F | 63 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 4 Jahre |
J. Goater | M | 48 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | - |
Anja Koenig | M | 54 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 5 Jahre |
Jodie Morrison | F | 48 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 4 Jahre |
Cameron Wheeler | M | 45 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | - |
James E. Audia | M | 68 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 6 Jahre |
Jacob Berlin | M | - |
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | - |
Gary Sutton | M | - |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 15 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sudha Parasuraman
- Persönliches Netzwerk